CoChat

Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection

Open access
Saunders, Kevin O., Pegu, Amarendra, Georgiev, Ivelin S., Zeng, Ming, Joyce, M. Gordon, Yang, Zhi-Yong, Ko, Sung-Youl, Chen, Xuejun, Schmidt, Stephen D., Haase, Ashley T., Todd, John-Paul, Bao, Saran, Kwong, Peter D., Rao, Srinivas S., Mascola, John R., Nabel, Gary J. · 2015 · Journal of Virology
Cited by 104

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Pathogen-specific neutralizing antibodies protect against many viral infections and can potentially prevent human immunodeficiency virus (HIV) transmission in humans. However, neutralizing antibodies have so far only been shown to protect nonhuman primates (NHP) against lentiviral infection when given shortly before challenge. Thus, the clinical utility and feasibility of passive antibody transfer to confer long-term protection against HIV-1 are still debated. Here, we investigate the potential of a broadly neutralizing HIV-1 antibody to provide long-term protection in a NHP model of HIV-1 infection. A human antibody was simianized to avoid immune rejection and used to sustain therapeutic levels for ∼5 months. Two months after the final antibody administration, animals were completely protected against viral challenge. These findings demonstrate the feasibility and potential of long-term passive antibody for protection against HIV-1 in humans and provide a model to test antibody therapies for other diseases in NHP. IMPORTANCE Antibodies against HIV are potential drugs that may be able to prevent HIV infection in humans. However, the long-term protective capacity of antibodies against HIV has not been assessed. Here, we repetitively administered a macaque version of a human anti-HIV antibody to monkeys, after which the antibody persisted in the blood for >5 months. Moreover, the antibody could be sustained at protective levels for 108 days, conferring protection 52 days after the last dose in a monkey model of HIV infection. Thus, passive antibody transfer can provide durable protection against infection by viruses that cause AIDS in primates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.00210-15

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 104

Metadata

Authors
Saunders, K. O., Pegu, A., Georgiev, I. S., Zeng, M., Joyce, M. G., Yang, Z.-Y., Ko, S.-Y., Chen, X., Schmidt, S. D., Haase, A. T., Todd, J.-P., Bao, S., Kwong, P. D., Rao, S. S., Mascola, J. R., & Nabel, G. J.
Venue
Journal of Virology
Published
2015-06
Volume
89
Issue
11
Pages
5895-5903
ISSN
  • 0022-538X (ISSN-L)
  • 1098-5514
OpenAlex
W1919421000
Cited by
104
References
5
FWCI
7.87
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection. https://app.cochat.ai/papers/10.1128/jvi.00210-15
The paper
Saunders, K. O., Pegu, A., Georgiev, I. S., Zeng, M., Joyce, M. G., Yang, Z.-Y., Ko, S.-Y., Chen, X., Schmidt, S. D., Haase, A. T., Todd, J.-P., Bao, S., Kwong, P. D., Rao, S. S., Mascola, J. R., & Nabel, G. J. (2015). Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection. Journal of Virology. https://doi.org/10.1128/jvi.00210-15

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.